Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2026 for Atossa Therapeutics, INC.. Read the official filing
Filing timeline
BuySaleH. Lawrence Remmel
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
H. Lawrence Remmel: trading record in brief
H. Lawrence Remmel, listed as senior executive, appears in our data through filings on Atossa Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 26 March 2025 and the latest from 12 May 2026.
The open-market record is one-sided, with 1 purchase worth €6,489 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.
The latest filing, published on 14 May 2026, reports a share grant in Atossa Therapeutics, Inc. The most recent open-market purchase was published on 28 March 2025, 569 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to H. Lawrence Remmel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares0Common StockSEC:0001193125-26-224140:0
10,000 shares@ US$0.70100.0% of flowCommon StockSEC:0000950170-25-046742:0
Canonical exit: 24 Jun 2025 (T+90)
2 of 2 declarations
